Advanced search
Publication Cover
Modern Rheumatology Volume 21, 2011 - Issue 6
Journal homepage
59
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials

Masaaki MoriYokohama City University School of Medicine, Yokohama, Japan;Department of Pediatrics, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, JapanCorrespondence[email protected]
,
Syuji TakeiKagoshima University School of Medicine, Kagoshima, Japan
,
Tomoyuki ImagawaYokohama City University School of Medicine, Yokohama, Japan
,
Hiroyuki ImanakaKagoshima University School of Medicine, Kagoshima, Japan
,
Yasuhito NeromeKagoshima University School of Medicine, Kagoshima, Japan
,
Rumiko KurosawaYokohama City University School of Medicine, Yokohama, Japan
,
Yoshifumi KawanoKagoshima University School of Medicine, Kagoshima, Japan
,
Shumpei YokotaYokohama City University School of Medicine, Yokohama, Japan
,
Noriko SugiyamaPfizer Inc, Tokyo, Japan
,
Hirotoshi YuasaPfizer Inc, Tokyo, Japan
,
Tracey FletcherPfizer Inc, Collegeville, PA, USA
&
Joseph S. WajdulaPfizer Inc, Collegeville, PA, USA
 show all
Pages 572-578 | Received 14 Jan 2011, Accepted 18 Mar 2011, Published online: 02 Jan 2014

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Masaaki Mori, Naonobu Sugiyama, Yosuke Morishima, Noriko Sugiyama, Takeshi Kokubo, Syuji Takei & Shumpei Yokota. (2018) Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance. Modern Rheumatology 28:1, pages 101-107.
Read now
Masaaki Mori, Syuji Takei, Tomoyuki Imagawa, Hiroyuki Imanaka, Yasuhito Nerome, Rumiko Higuchi, Yoshifumi Kawano, Shumpei Yokota, Noriko Sugiyama, Hirotoshi Yuasa, Tracey Fletcher & Joseph S. Wajdula. (2012) Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan. Modern Rheumatology 22:5, pages 720-726.
Read now

Articles from other publishers (6)

Ruud H. J. Verstegen, Peter Shrader, Stephen J. Balevic, Timothy Beukelman, Colleen Correll, Anne Dennos, Thomas Phillips & Brian M. Feldman. (2022) Dosing Variation at Initiation of Adalimumab and Etanercept and Clinical Outcomes in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study. Arthritis Care & Research 75:2, pages 410-422.
Crossref
Job Gieling, Bart van den Bemt, Esther Hoppenreijs & Ellen Schatorjé. (2022) Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors. Pediatric Rheumatology 20:1.
Crossref
Ruud H J Verstegen, Rhona McMillan, Brian M Feldman, Shinya Ito & Ronald M Laxer. (2020) Towards therapeutic drug monitoring of TNF inhibitors for children with juvenile idiopathic arthritis: a scoping review. Rheumatology 59:2, pages 386-397.
Crossref
Masaaki Mori, Masao Nakagawa, Nao Tsuchida, Kou Kawada, Junko Sato, Michiyo Sakiyama, Shinya Hirano, Katsuaki Sato & Hidefumi Nakamura. (2018) Proposal for the development of biologics in pediatric rheumatology. Pediatrics International 60:2, pages 108-114.
Crossref
Lesley J. Scott. (2014) Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases. Drugs 74:12, pages 1379-1410.
Crossref
Wendy J. Ungar, Vania Costa, Heather F. Burnett, Brian M. Feldman & Ronald M. Laxer. (2013) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: A systematic review. Seminars in Arthritis and Rheumatism 42:6, pages 597-618.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.